Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The pathogenesis of stroke, trauma and chronic degenerative diseases, such as Alzheimer's disease (AD), has been linked to excitotoxic processes due to inappropriate stimulation of the N‐methyl‐d‐asparate receptor (NMDA‐R). Attempts to use potent competitive NMDA‐R antagonists as neuroprotectants have shown serious side‐effects in patients. As an alternative approach, we were interested in the anti‐excitotoxic properties of memantine, a well‐tolerated low affinity uncompetitive NMDA‐R antagonist presently used as an anti‐dementia agent. We explored in a series of models of increasing complexity, whether this voltage‐dependent channel blocker had neuroprotective properties at clinically relevant concentrations. As expected, memantine protected neurons in organotypic hippocampal slices or dissociated cultures from direct NMDA‐induced excitotoxicity. However, low concentrations of memantine were also effective in neuronal (cortical neurons and cerebellar granule cells) stress models dependent on endogenous glutamate stimulation and mitochondrial stress, i.e. exposure to hypoxia, the mitochondrial toxin 1‐methyl‐4‐phenylpyridinium (MPP+) or a nitric oxide (NO) donor. Furthermore, memantine reduced lethality and brain damage in vivo in a model of neonatal hypoxia‐ischemia (HI). Finally, we investigated functional rescue (neuronal capacity to migrate along radial glia) by memantine in cerebellar microexplant cultures exposed to the indirect excitotoxin 3‐nitropropionic acid (3‐NP). Potent NMDA‐R antagonists, such as (+)MK‐801, are known to block neuronal migration in microexplant cultures. Interestingly, memantine significantly restored the number of neurons able to migrate out of the stressed microexplants. These findings suggest that inhibition of the NMDA‐R by memantine is sufficient to block excitotoxicity, while still allowing some degree of signalling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Memantine in Moderate-to-Severe Alzheimer's Disease
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043
Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond
Lipton, S. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1958 · Cited by 909 · cited 3×
“memantine, like Mg, leaves the NMDA-R channel due to its voltage-dependency and fast unblocking kinetics (reviewed in Kornhuber & Weller, 1997; Lipton, 2006).”
BackgroundInfluentialClementi, E., Brown, G. C., Feelisch, M., & Moncada, S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7631 · Cited by 863
Alternative excitotoxic hypotheses
Albin, R. L., & Greenamyre, J. T. (1992) · Neurology · doi:10.1212/wnl.42.4.733 · Cited by 574 · cited 1×
“…AD are believed not necessarily to depend only on increased glutamate levels per se, but also on increased receptor sensitivity and over-activation by resting levels of glutamate (Albin & Greenamyre, 1992), followed by release of endogenous glutamate (Henneberry et al., 1989; Choi & Rothman, 1990).”
BackgroundDanysz, W., & Parsons, C. G. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.938 · Cited by 404
Cited by
Danysz, W., & Parsons, C. G. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02057.x · Cited by 500
Mitochondrial Dysfunction and Glaucoma
Kong, G. Y. X., Van Bergen, N. J., Trounce, I. A., & Crowston, J. G. (2009) · Journal of Glaucoma · doi:10.1097/ijg.0b013e318181284f · Cited by 261
Grossberg, G., & Thomas, S. (2009) · Clinical Interventions in Aging · doi:10.2147/cia.s6666 · Cited by 151
“Studies in animals have suggested that memantine is neuroprotective(51) but will still allow signaling and normal function.(52,53) This is the reason memantine is clinically such a well tolerated drug.”
Schildknecht, S., Pöltl, D., Nagel, D. M., Matt, F., Scholz, D., Lotharius, J., Schmieg, N., Salvo-Vargas, A., & Leist, M. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.07.027 · Cited by 115
Self-citationChalupova, K., Korabecny, J., Bartolini, M., Monti, B., Lamba, D., Caliandro, R., Pesaresi, A., Brazzolotto, X., Gastellier, A.-J., Nachon, F., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.02.021 · Cited by 118
Metadata
- Authors
- Volbracht, C., Van Beek, J., Zhu, C., Blomgren, K., & Leist, M.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2006-05
- Volume
- 23
- Issue
- 10
- Pages
- 2611-2622
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W2095710801
- Cited by
- 174
- References
- 5
- FWCI
- 3.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity. https://app.cochat.ai/papers/10.1111/j.1460-9568.2006.04787.x
- The paper
- Volbracht, C., Van Beek, J., Zhu, C., Blomgren, K., & Leist, M. (2006). Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity. European Journal of Neuroscience. https://doi.org/10.1111/j.1460-9568.2006.04787.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.